Formoterol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Formoterol. Educational only — not medical advice.
Labeled uses
DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions (5.1 , 5.4 )] .
Source: FDA labeling via NIH DailyMed (set 2eba3089…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.